Vertex Pharmaceuticals | Vertex Announces UK MHRA Approval of ALYFTREK® (Deutivacaftor/Tezacaftor...
The official Investor Relations website for Vertex Pharmaceuticals, which contains information for shareholders, potential investors, and financial analysts.
investors.vrtx.com